View Older Stories View More Recent Stories

Nov 5, 2024 10:56PM KKR acquires 35% of Fuji Soft after first stage of tender offer
Oct 21, 2024 07:27PM Fuji Soft's top shareholder confirms support for KKR takeover bid
Oct 21, 2024 04:03AM KKR extends tender period for Fuji Soft to November
Oct 18, 2024 05:03AM Fuji Soft board backs first stage of KKR's buyout offer
Oct 17, 2024 09:33AM Fuji Soft founder backs buyout by Bain over KKR offer, letter says
Oct 16, 2024 04:36PM Form SC 13D Squarespace, Inc. Filed by: Farallon Capital Partners, L.P.
Sep 4, 2024 08:00AM eGenesis Raises $191 Million Series D Financing to Advance Lead Program for Kidney Transplant
Sep 3, 2024 08:41AM Form N-PX FARALLON CAPITAL MANAGEM For: Jun 30
Aug 22, 2024 12:44PM Newmark Secures $985 Million Financing on Behalf of 80 Clarkson Developers in New York City
Aug 14, 2024 01:32PM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
Aug 14, 2024 01:31PM Form 13F-NT Farallon Capital Europe For: Jun 30
Aug 14, 2024 01:30PM Form 13F-HR FARALLON CAPITAL MANAGEM For: Jun 30
Aug 14, 2024 06:14AM Anaptysbio (ANAB) Prices 2.75M Share Offering at $36.50/sh
Aug 14, 2024 05:00AM Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
Jul 16, 2024 09:00AM Cardurion Pharmaceuticals Announces $260 Million Series B Financing to Advance Its Pipeline of Innovative Medicines for Cardiovascular Diseases
Jul 8, 2024 07:34AM CASI Pharmaceuticals (CASI) announces appointment of Daniel Lang, MD as CFO and SVP
Jul 8, 2024 07:30AM CASI Pharmaceuticals announces appointment of Daniel Lang, MD as CFO and SVP
Jul 3, 2024 09:12AM Form D/A Farallon Capital F5 Inve
Jul 3, 2024 09:07AM Form D/A Farallon Capital F5 Inve
Jun 28, 2024 08:50AM Savara (SVRA) Announces Pricing of $100.0 Million Underwritten Offering of Common Stock
Jun 28, 2024 08:50AM Savara Announces Pricing of $100.0 Million Underwritten Offering of Common Stock
Jun 20, 2024 04:01PM Tectonic Therapeutic Announces Closing of Merger with AVROBIO as well as Concurrent Private Placement of $130.7 Million
May 24, 2024 03:06PM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
May 17, 2024 04:59PM Form SC 13G NanoString Technologies Filed by: Farallon Capital Partners, L.P.
May 15, 2024 11:18AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
May 15, 2024 11:17AM Form 13F-NT Farallon Capital Europe For: Mar 31
May 15, 2024 11:16AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Sep 30
May 15, 2024 11:14AM Form 13F-HR FARALLON CAPITAL MANAGEM For: Mar 31
May 8, 2024 04:11PM Form SC 13D/A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
May 2, 2024 04:01PM Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates
Apr 8, 2024 06:34AM Ladenburg Thalmann Upgrades Forte Biosciences Inc. (FBRX) to Buy
Mar 25, 2024 11:25AM Zambia External Bondholder Steering Committee Reaches Agreement with Zambia on Debt Restructuring
Mar 21, 2024 07:00AM Mirador Therapeutics Launches to Accelerate the Next Generation of Precision Medicines for Immune-mediated Diseases
Mar 19, 2024 09:07AM Geron Corp (GERN) Prices $150M Share and Warrant Offering at $3/sh
Mar 19, 2024 09:07AM Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Mar 18, 2024 08:07AM Spyre Therapeutics (SYRE) announced $180M private placement
Mar 18, 2024 08:00AM Spyre Therapeutics Announces $180 Million Private Placement
Mar 8, 2024 08:51AM Form D/A Farallon Capital Institu
Mar 8, 2024 08:47AM Form D/A Farallon Capital (AM)
Mar 8, 2024 08:43AM Form D/A FARALLON CAPITAL OFFSHOR
Mar 8, 2024 08:39AM Form D/A Farallon Capital Partner
Mar 7, 2024 08:02AM Ventyx Biosciences (VTYX) Prices 11.17M Share Offering at $8.95/sh
Mar 7, 2024 08:00AM Ventyx Biosciences Announces $100 Million Private Placement of Common Stock
Mar 1, 2024 07:00AM FogPharma Announces $145 Million Financing to Support Ongoing Clinical Development of FOG-001 and Accelerate Helicon Peptide Portfolio
Feb 14, 2024 09:33AM Form SC 13G/A Forte Biosciences, Inc. Filed by: Farallon Capital Partners, L.P.
Feb 14, 2024 08:42AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
Feb 14, 2024 08:24AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
Feb 14, 2024 08:24AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Sep 30
Feb 14, 2024 08:23AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
Feb 14, 2024 08:23AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
View More Recent Stories View Older Stories